These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8927047)

  • 41. Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake.
    Tsiani E; Abdullah N; Fantus IG
    Am J Physiol; 1997 Jan; 272(1 Pt 1):C156-62. PubMed ID: 9038821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver.
    Nakagawa Y; Aoki N; Aoyama K; Shimizu H; Shimano H; Yamada N; Miyazaki H
    Zoolog Sci; 2005 Feb; 22(2):169-75. PubMed ID: 15738637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
    Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
    Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defects of insulin's signal transduction in old rat livers.
    Nadiv O; Cohen O; Zick Y
    Endocrinology; 1992 Mar; 130(3):1515-24. PubMed ID: 1311243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of insulin dissociation from its endosomal receptor in insulin degradation.
    Bevan AP; Seabright PJ; Tikerpae J; Posner BI; Smith GD; Siddle K
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):145-57. PubMed ID: 11026566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of peroxovanadate and vanadate on insulin binding, degradation and sensitivity in rat adipocytes.
    Yu ZW; Posner BI; Smith U; Eriksson JW
    Biochim Biophys Acta; 1996 Jan; 1310(1):103-9. PubMed ID: 9244182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of the ICAM-1 gene transcription by the peroxovanadium compound [bpV(Pic)] involves STAT-1 but not NF-kappa B activation in 293 cells.
    Audette M; Larouche L; Lussier I; Fugère N
    Eur J Biochem; 2001 Mar; 268(6):1828-36. PubMed ID: 11248703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of phosphotyrosine phosphatase inhibition on insulin secretion and intracellular signaling events in rat pancreatic islets.
    Gogg S; Chen J; Efendic S; Smith U; Ostenson C
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1161-8. PubMed ID: 11162649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity.
    Mosthaf L; Berti L; Kellerer M; Mushack J; Seffer E; Bossenmaier B; Coghlan M; Siddle K; Ullrich A; Häring HU
    Eur J Biochem; 1995 Feb; 227(3):787-91. PubMed ID: 7867639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.
    Crans DC; Mahroof-Tahir M; Keramidas AD
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):17-24. PubMed ID: 8927035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation.
    Pandey SK; Anand-Srivastava MB; Srivastava AK
    Biochemistry; 1998 May; 37(19):7006-14. PubMed ID: 9578588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats.
    Abella A; Marti L; Camps M; Claret M; Fernández-Alvarez J; Gomis R; Gumà A; Viguerie N; Carpéné C; Palacín M; Testar X; Zorzano A
    Diabetes; 2003 Apr; 52(4):1004-13. PubMed ID: 12663473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.
    Rehder D; Costa Pessoa J; Geraldes CF; Castro MC; Kabanos T; Kiss T; Meier B; Micera G; Pettersson L; Rangel M; Salifoglou A; Turel I; Wang D
    J Biol Inorg Chem; 2002 Apr; 7(4-5):384-96. PubMed ID: 11941496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dephosphorylation of human insulin-like growth factor I (IGF-I) receptors by membrane-associated tyrosine phosphatases.
    Peraldi P; Hauguel-de Mouzon S; Alengrin F; Van Obberghen E
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):71-8. PubMed ID: 1322128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of fluoride on insulin receptor autophosphorylation and tyrosine kinase activity.
    Viñals F; Testar X; Palacín M; Zorzano A
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):615-22. PubMed ID: 7683457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
    Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
    Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Res Rev; 2012 May; 32(3):459-517. PubMed ID: 20814956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
    Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arylalkylamine vanadium salts as new anti-diabetic compounds.
    Zorzano A; Palacín M; Marti L; García-Vicente S
    J Inorg Biochem; 2009 Apr; 103(4):559-66. PubMed ID: 19246098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.